SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P20
Within normal range
vs 3Y Ago
-62.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -156.10% |
| Q3 2025 | 490.83% |
| Q2 2025 | -94.64% |
| Q1 2025 | 54.47% |
| Q4 2024 | -9.82% |
| Q3 2024 | -41.77% |
| Q2 2024 | -46.30% |
| Q1 2024 | 86.01% |
| Q4 2023 | -297.94% |
| Q3 2023 | 28.68% |
| Q2 2023 | 6.85% |
| Q1 2023 | 6.41% |
| Q4 2022 | 2.50% |
| Q3 2022 | -44.14% |
| Q2 2022 | -582.61% |
| Q1 2022 | 105.60% |
| Q4 2021 | -5380.00% |
| Q3 2021 | 88.97% |
| Q2 2021 | -312.50% |
| Q1 2021 | 15338.10% |
| Q4 2020 | 0.00% |